BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28641998)

  • 1. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
    Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
    Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
    Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to various epitopes of hepatitis B surface antigen inhibit hepatitis B virus infection.
    Golsaz Shirazi F; Mohammadi H; Amiri MM; Singethan K; Xia Y; Bayat AA; Bahadori M; Rabbani H; Jeddi-Tehrani M; Protzer U; Shokri F
    J Gastroenterol Hepatol; 2014 May; 29(5):1083-91. PubMed ID: 24325676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and expression of hepatitis B surface antigen escape variants within the "a" determinant by site directed mutagenesis.
    Golsaz Shirazi F; Amiri MM; Mohammadi H; Bayat AA; Roohi A; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Kardar GA; Shokri F
    Iran J Immunol; 2013 Sep; 10(3):127-38. PubMed ID: 24076590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.
    Wang W; Sun L; Li T; Ma Y; Li J; Liu Y; Li M; Wang L; Li C; Xie Y; Wen Y; Liang M; Chen L; Tong S
    MAbs; 2016; 8(3):468-77. PubMed ID: 26713590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Golsaz-Shirazi F; Mohammadi H; Amiri MM; Khoshnoodi J; Kardar GA; Jeddi-Tehrani M; Shokri F
    Arch Virol; 2016 Oct; 161(10):2765-72. PubMed ID: 27439498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
    Ryu CJ; Gripon P; Park HR; Park SS; Kim YK; Guguen-Guillouzo C; Yoo OJ; Hong HJ
    J Med Virol; 1997 Jun; 52(2):226-33. PubMed ID: 9179773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg).
    Shin YW; Ryoo KH; Hong KW; Chang KH; Choi JS; So M; Kim PK; Park JY; Bong KT; Kim SH
    Antiviral Res; 2007 Aug; 75(2):113-20. PubMed ID: 17343928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a high-affinity chimaeric antibody against hepatitis B surface antigen.
    Bose B; Khanna N; Acharya SK; Sinha S
    Biotechnol Appl Biochem; 2006 Feb; 43(Pt 2):93-101. PubMed ID: 16253117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
    Cooreman MP; Leroux-Roels G; Paulij WP
    J Biomed Sci; 2001; 8(3):237-47. PubMed ID: 11385295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant.
    Sloan RD; Ijaz S; Moore PL; Harrison TJ; Teo CG; Tedder RS
    Antivir Ther; 2008; 13(3):439-47. PubMed ID: 18572757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Characterization of Murine Monoclonal Antibody Variable Regions Specific for Hepatitis B Surface Antigen.
    Golsaz-Shirazi F; Amiri MM; Bahadori M; Bayat AA; Mohammadi H; Farid S; Maddah M; Khoshnoodi J; Zarnani AH; Jeddi-Tehrani M; Shokri F
    Viral Immunol; 2015 Oct; 28(8):425-33. PubMed ID: 26425894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
    Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
    Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis.
    Maillard P; Pillot J
    Res Virol; 1998; 149(3):153-61. PubMed ID: 9711539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of anti HBs monoclonal antibody and its combination characterization to both wild-type HBsAg and immune escape mutant HBsAg].
    Li FH; Zhang XY; Yan B; Zhang B; Huang YG; Zhang CY; Gong JS; Chen Y; Liu JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):594-6. PubMed ID: 18538091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccination.
    Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
    Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches.
    Alves Vianna CO; da Silva E Mouta Júnior S; da Glória Teixeira Martins M; Batoreu NM; Queiroz JL; Gomes SA; Magalhães de Andrade Góes AC; Garcia Armoa GR; Marques CH; Baroni de Moraes MT
    J Immunol Methods; 2006 Jun; 313(1-2):38-47. PubMed ID: 16753174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, expression and characterization of a murine-human chimeric antibody with specificity for pre-S2 surface antigen of hepatitis B virus.
    Jin BR; Ryu CJ; Park SS; Namgung U; Hong HJ; Han MH
    Mol Immunol; 1993 Dec; 30(18):1647-54. PubMed ID: 8272078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.